Novartis, Microsoft ink 5-year AI alliance

Share

Novartis announced a five-year partnership with Microsoft in a bet that the tech company can help it make better sense of the data they generate from lab experiments, clinical trials, and manufacturing plants.

 

They will develop applications for Microsoft’s AI capabilities throughout Novartis’ drug development, focusing first on personalizing treatment for age-related macular degeneration and on improving manufacturing of CAR-T cancer therapies.

 

Additionally, through a new AI innovation lab, the companies hope to make AI-powered applications accessible and usable across Novartis’ organization.

 

Read the full article at biopharmadive.com…

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

More in News & Trends
FierceBiotech’s 2019 Fierce 15

Once again, FierceBiotech has honored a group of hard working and cutting-edge biotech companies with their Fierce 15 award. This...

Close